Scarica l'app Stockscreener
24.94
1.71%
0.42
Dopo l'orario di chiusura:
24.75
-0.19
-0.76%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$24.52
Aprire:
$24.94
Volume 24 ore:
2.98M
Relative Volume:
0.57
Capitalizzazione di mercato:
$4.45B
Reddito:
$644.86M
Utile/perdita netta:
$196.05M
Rapporto P/E:
25.42
EPS:
0.9812
Flusso di cassa netto:
$317.50M
1 W Prestazione:
-4.48%
1M Prestazione:
+15.89%
6M Prestazione:
-2.00%
1 anno Prestazione:
-62.17%
Intervallo 1D:
$24.75
$25.28
Intervallo di 1 settimana:
$23.95
$26.70
Portata 52W:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, TXG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.94 | 4.37B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
242.75 | 38.72B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
59.50 | 11.95B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
49.36 | 9.32B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
102.79 | 8.56B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
55.63 | 7.56B | 638.78M | -22.66M | 122.18M | -0.1744 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-20 | Downgrade | Truist | Buy → Hold |
| 2026-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-10-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Downgrade | Goldman | Neutral → Sell |
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
Doximity (NYSE:DOCS) Valuation Debate Gets More Interesting - Kalkine Media
A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know - fool.com
What Investors Should Know of This Doximity Officer's Latest Insider Transaction - The Motley Fool
Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know. - The Motley Fool
Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About? - The Motley Fool
Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors - Yahoo Finance
What Investors Should Know of This Doximity Officer's Latest Insider Transaction - The Motley Fool
Doximity (DOCS) Q1 2027 Earnings Call Transcript - AOL.com
Is Doximity (DOCS) Turning Rising AI Revenue Into Sustainable Profits Or Margin Trade-Offs? - webull.com
Doximity CAO Siddharth Sitaram sells $44,143 of class A stock By Investing.com - Investing.com South Africa
Doximity CAO Siddharth Sitaram sells $44,143 of class A stock - Investing.com
Doximity (NYSE:DOCS) CAO Siddharth Sitaram Sells 1,770 Shares of Stock - MarketBeat
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 17.38% Potential Upside Amidst Health Information Services Growth - DirectorsTalk Interviews
Bank of America Corp DE Grows Position in Doximity, Inc. $DOCS - MarketBeat
Rapid7, 8x8, Doximity, Marqeta, and Tenable Shares Are Soaring, What You Need To Know - Yahoo Finance
Clinical AI Use Surges as Revenue Climbs & Doctors Embrace New Tools - Streetwise Reports
The 5 Most Interesting Analyst Questions From Doximity’s Q2 Earnings Call - Yahoo Finance
DOCS Stock Soars After CEO Says Clinical AI Outperformed Anthropic, Wall Street Lifts Price Targets - Stocktwits
Doximity AI Tools Fuel Physician Engagement Growth Amid Healthcare Digital Shift - Streetwise Reports
DOCS|Doximity Inc|Price:25.030|Chg%:-1.560 - TradingKey
Doximity (NYSE:DOCS) Trading Down 5.6%Here's Why - MarketBeat
Doximity, Inc. (DOCS) Q4 2025 Earnings – Full Coverage Heather Watson (LwrmLN9W8f) - Mshale
Royal Bank of Canada Has $4.81 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity Inc (DOCS) Shares Surge 6.4% -- What GF Score of 86 Tel - GuruFocus
Doximity Doubled, Then Gave Most of It Back. Here’s Why the Market Doesn’t Trust the Rally - Yahoo Finance
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo! Finance Canada
Doximity (NYSE: DOCS) insider schedules 1,770-share stock option sale - Stock Titan
Truist Lifts Doximity Target to $24 and Stays on Hold - TradingView
Truist raises Doximity stock price target on updated model By Investing.com - Investing.com Australia
Doximity, Inc. : Truist Securities Raises Tar - Moomoo
Truist raises Doximity stock price target on updated model - Investing.com
Doximity Inc (DOCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is Doximity Inc (DOCS) a Bargain After 4.3% Drop? GF Value Says Undervalued - GuruFocus
Mizuho Securities Maintains Doximity(DOCS.US) With Hold Rating, Raises Target Price to $28 - Moomoo
Doximity director Timothy Cabral sells $293,325 in company stock By Investing.com - Investing.com India
Doximity, Inc. (DOCS) stock price, news, quote and history - Yahoo Finance UK
Doximity director Timothy Cabral sells $293,325 in company stock - Investing.com
First Trust Advisors LP Cuts Stock Position in Doximity, Inc. $DOCS - MarketBeat
Timothy Cabral Sells 7,500 Shares of Doximity (NYSE:DOCS) Stock - MarketBeat
Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup - The Motley Fool
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.46%
7.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):